Related Experiment Video
Updated: Apr 25, 2026

JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics
Published on: October 19, 2021
Proteome-genome complexity as a metric of refractory disease
1Brookdale University Hospital and Medical Center, One Brookdale Plaza, Brooklyn, NY 11212, United States.
Abstract:
Treatment decisions for refractory diseases are frequently challenging because the benefits of disease-free survival and relief of symptoms must be balanced against the severity and frequency of side effects. A precise measure of disease resistance would therefore be valuable when assessing possible treatment strategies. In recent years there has been much interest in the modeling of proteomes and genomes as a means of identifying major pathways of disease causation. We suggest that these analyses may offer the additional benefit of quantifying refractory.
Insights
Quantifying disease resistance is crucial for refractory diseases. Proteome and genome modeling may offer a novel way to measure this resistance, aiding treatment decisions.
Area of Science:
- Biochemistry and Molecular Biology
- Genomics and Proteomics
- Translational Medicine
Background:
- Treatment decisions for refractory diseases require balancing treatment benefits against side effect severity.
- Accurate measures of disease resistance are needed for effective therapeutic strategies.
- Recent advancements in genome and proteome modeling offer new avenues for biological insights.
Discussion:
- Proteome and genome modeling can identify disease-causing pathways.
- These modeling approaches may provide a quantitative measure of disease refractoriness.
- This quantification could significantly aid in selecting optimal treatment strategies for challenging conditions.
Key Insights:
- Disease refractoriness quantification is a significant challenge in clinical practice.
- Proteomic and genomic analyses are emerging tools for understanding disease mechanisms.
- The study proposes leveraging these analyses to quantify disease resistance.
Outlook:
- Further research into proteomic and genomic modeling is warranted.
- Developing precise measures of disease resistance could revolutionize treatment planning.
- This approach holds promise for improving patient outcomes in refractory diseases.
Related Concept Videos
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Genomics
Genome Size and the Evolution of New Genes
Genome Size and the Evolution of New Genes
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Evolution of Microbial Genome

